Regulation of apoptosis and cell cycle progression plays an essential role in the maintenance of B-cell homeostasis, because a fine balance of survival and expansion is critical for preventing lymphocytic disorders. Although remarkable progress in understanding B-cell development has been achieved, much less is known concerning niches that are critical to the maintenance of B-cell homeostasis. Leptin has recently been recognized to be important for modulating the immune responses, but it has remained unclear how leptin signaling influences B-cell physiology. A variety of lymphocytic malignancies have been reported to be linked to leptin, and therefore it is necessary to elucidate the mechanisms involved. Here we demonstrate that leptin promotes B-cell homeostasis by inhibiting apoptosis and by inducing cell cycle entry through the activation of expressions of B-cell CLL/lymphoma 2 (Bcl-2) and cyclin D1. We further show that leptin can induce Bcl-2 and cyclin D1 expression by two pathways, including the direct activation of their promoters and suppression of microRNAs (miRNAs) that target their putative 3′untranslated regions. Amplification of these leptin-modulated miRNAs inhibited B lymphoma cell growth. These findings provide insights into mechanisms for leptin regulation of the humoral immune system and suggest new therapeutic strategies for leptin receptor expressing malignancies.
Regulation of apoptosis and cell cycle progression plays an essential role in the maintenance of B-cell homeostasis, because a fine balance of survival and expansion is critical for preventing lymphocytic disorders. Although remarkable progress in understanding B-cell development has been achieved, much less is known concerning niches that are critical to the maintenance of B-cell homeostasis. Leptin has recently been recognized to be important for modulating the immune responses, but it has remained unclear how leptin signaling influences B-cell physiology. A variety of lymphocytic malignancies have been reported to be linked to leptin, and therefore it is necessary to elucidate the mechanisms involved. Here we demonstrate that leptin promotes B-cell homeostasis by inhibiting apoptosis and by inducing cell cycle entry through the activation of expressions of B-cell CLL/lymphoma 2 (Bcl-2) and cyclin D1. We further show that leptin can induce Bcl-2 and cyclin D1 expression by two pathways, including the direct activation of their promoters and suppression of microRNAs (miRNAs) that target their putative 3′untranslated regions. Amplification of these leptin-modulated miRNAs inhibited B lymphoma cell growth. These findings provide insights into mechanisms for leptin regulation of the humoral immune system and suggest new therapeutic strategies for leptin receptor expressing malignancies.
B cell survival | apoptosis | proliferation | microRNA A poptosis plays an essential role in the maintenance of B-cell homeostasis, a process that is regulated by a fine balance between the continual generation of new B lymphocytes and their elimination through multiple checkpoints in both bone marrow (BM) and secondary lymphoid organs (1) . The balance between B cell survival and death is critical because excessive apoptosis may lead to immunodeficiencies whereas insufficient apoptosis may result in autoimmunity and even lymphoid malignancies (2) . B cells that are optimally activated escape apoptosis and transit through different cell cycle checkpoints. B-cell CLL/lymphoma 2 (Bcl-2) family proteins, which function to preserve or disturb mitochondrial integrity, are required for the maintenance of immune homeostasis (2, 3) . Targeted loss of the antiapoptotic member gene Bcl-2 has led to massive apoptosis of lymphocytes, whereas overexpression of Bcl-2 has caused the accumulation of B cells (4, 5) . D-type cyclins are key players in the G 1 checkpoint control mechanism and are critical for cell proliferation (6) . Both Bcl-2 and D-type cyclins are prime targets for novel therapeutics because their overexpression is common in many hematological diseases and many types of cancers (7, 8) . MicroRNAs (miRNAs) are increasingly recognized for their prominent role in immune homeostasis, while the accumulating evidence for aberrant miRNA expression in B-cell-derived tumors underscores miRNAs as potential targets for cancer therapeutics (9) . Therefore, elucidation of the regulatory mechanisms of miRNAs in peripheral B cells will contribute to a fuller understanding of B cell biology.
Leptin, originally discovered as an endocrine hormone, has been shown to play a crucial role in modulating immune responses (10) (11) (12) . Earlier studies on leptin deficient ob/ob and leptinreceptor-deficient db/db mice showed markedly reduced numbers of lymphocytes with impaired humoral responses, but many questions remain about the molecular mechanisms (13, 14) . A variety of human cancer cells express the leptin receptor and show enhanced proliferation in response to leptin stimulation (11) . Common polymorphisms in the leptin gene or its receptor are linked to the pathogenesis of various hematological malignancies including nonHodgkin's lymphoma (15) . Serum leptin level was significantly elevated in patients with multiple myeloma and chronic lymphocytic leukemia (16) . It is therefore important to understand how leptin signaling is involved in such malignancies (17) . In this study we present direct evidence that leptin maintains B-cell homeostasis by protecting them from apoptosis and inducing cell-cycle entry via the induction of Bcl-2 and cyclin D1. Leptin elevates Bcl-2 and cyclin D1 levels through at least two mechanisms, by activating their promoters and suppressing miRNAs that target the putative 3′untranslated regions (UTR) of Bcl-2 and cyclin D1 mRNAs. Amplification of these leptin-modulated miRNAs led to suppression of Bcl-2 and/or cyclin D1 expression and inhibition of B lymphoma cell growth. These results demonstrate critical roles for leptin in B cell survival as well as proliferation, and suggest new targets for cancer therapy.
Results
Functional Leptin Receptors Are Expressed on B Lymphocytes. We began our study by confirming that the leptin receptor is expressed on various B lymphocyte subsets ( Fig. S1 A and B) . Because STAT3 is a major regulator of B-cell development, we examined its activity upon leptin treatment in B cells (18) . We found that phosphorylation of STAT3 occurred when leptin was added to spleen B cells in culture, whereas a significantly reduced level of phosphorylated STAT3 was found in db/db mouse B cells (Fig. S1 C and D) . However, these data do not exclude the possibility that leptin acts in part by an influence on components of lymphocyte niches. Therefore, we transferred equal numbers of db/db or WT CD19 + donors were observed in the spleens of db/db chimera (Fig. 1A) . As control, we detected very low frequency (3.6% ± 1.3%) of reconstituted CD45.2 + B cells in the recipients' spleens at 6 wk post transfer with only the B cell-depleted WT BM cells (Fig. S2A) 
IgM
− T3 B cells from the donors were also found to be reduced in the db/db chimera (Fig. S2B) . Also, B cells from the db/db donors with the B220
High MZ phenotype were reduced in frequency (Fig. S2B) . We also used an alternative staining scheme to confirm the reduced GC B cells in db/db chimeras (Fig. S2C) . Accordingly, the cell numbers of various B cell subsets from the donors were significantly reduced in db/db chimeras (Fig. 1B) . Immunization of the chimeras with TNP-Ficoll resulted in significantly reduced serum levels of TNP-specific IgM, IgA, IgG 1 and IgG 2a in db/db chimeras (Fig. S2D) . We conclude that leptin acts directly on a spectrum of B lymphocyte types, regulating their numbers under normal, steady-state conditions.
Leptin Signaling Promotes B-Cell Survival and Is Important for Proliferation. We observed increased numbers of early apoptotic Annexin V + 7AAD − cells in Tr, FO, MZ and GC subsets of db/db mice compared with WT controls ( Fig. 2A ). Similar observations were found in db/db T1, T2 and T3 B-cell subsets (Fig. S2E ). We then treated B cells with leptin in the absence or presence of antiIgM F(ab′)2 fragments (anti-IgM), CD40L, or LPS for 24 h and found that leptin protected B cells from apoptosis in all conditions (Fig. 2B) . We next performed a Mitotracker Red uptake assay and confirmed that leptin exerted antiapoptotic function via the mitochondrial pathway in the absence or presence of anti-IgM, CD40L, or LPS (Fig. 2C ). Leptin alone had limited influence but markedly enhanced the proliferation of B cells in the presence of costimulation as assessed by carboxyfluorescein succinimidyl ester (CFSE) assay (Fig. 2C) . Consistently, we observed significant increases in DNA replication as assessed by BrdU incorporation in the presence of leptin and costimulators (Fig. 2C ). Leptin treatment led to an increase in viable cell numbers (Fig. 2D) . We detected an increase in B cell size, enhanced surface expression of CD23, CD86, CD40, and MHC II, as well as migratory capacity of B cells when incubated with leptin either alone or in the presence of the stimuli, consistent with an activated state of B cells for entry into cell cycle ( Fig. 2 E and F) . Finally, we found significantly reduced uptake of BrdU in Tr, FO, MZ, and GC subsets of db/db mice compared with WT controls (Fig. 2G ). Similar observations were found in db/db T1, T2, and T3 B cell subsets (Fig. S2F) . These results suggest that in addition to attenuation of B-cell apoptosis, leptin induces cell-cycle entry. While in the presence of costimulation, leptin activates cell cycle progression in B cells.
Leptin Signaling Induces Bcl-2 and Cyclin D1 Expression in B Cells. We found markedly reduced Bcl-2 transcripts in all of the db/db Tr, FO, and MZ B cell subsets (Fig. 3A) . Bcl-xL expression was decreased only in the db/db MZ B cell subset, whereas the expression of Bax and Bim was increased in all db/db B cell subsets. Bad expression was only increased in db/db MZ B cells. Incubation of splenic WT B cells with leptin significantly induced Bcl-2 expression, but inhibited the expression of the proapoptotic Bcl-2 family proteins, Bax, Bim, and Bad (Fig. 3B) . Next, we used realtime PCR to analyze the expression of a panel of cell cycle regulators in the db/db Tr, FO and MZ subsets (Fig. 3C) . Cyclin D1 is the first cyclin produced in cell cycle in response to extracellular signals and allows quiescent cells to enter the G 1 phase. Consistent with a role of leptin in regulating genes relating to early G 1 , we detected marked reductions in cyclin D1 transcripts in db/db B cells. We also found significantly increased expression of p27 Kip1 in all of the db/db B cell subsets. These results were confirmed by incubating B cells with leptin (Fig. 3D) . Taken together, these data point to a positive effect of leptin on cell cycle regulation in B cells. Because leptin alone did not induce cell cycle progression, we further analyzed the gene expression profiles of leptin-treated B cells in the absence or presence of costimulation (Fig. 3E) . Consistently, cyclin E1, cyclin A2, and CDK2 were unchanged in B cells treated with leptin alone, but were markedly up-regulated on costimulation (Fig. 3E ). With BCR ligation or LPS stimulation, leptin could even up-regulate the expression of cyclin B1, an important activator of G 2 / M progression. These data indicate that leptin differentially regulates Bcl-2 family members and promotes cell cycle progression in B lymphocytes that are simultaneously receiving activation signals.
Leptin Signaling Activates Bcl-2 and Cyclin D1 Promoters Mediating Prosurvival Responses in B Cells. We next focused on determining how leptin modulates Bcl-2 and cyclin D1 levels. STAT-3, Akt, and NF-κB are known inducers of Bcl-2 and cyclin D1. As noted above, STAT3 was phosphorylated in B cells exposed to leptin in culture. We also observed significantly enhanced phosphorylation of Akt and PDK-1 upon leptin treatment (Fig. 4A ). In addition, leptin caused phosphorylation of IκB, the inhibitor of NF-κB, and stimulated the nuclear translocation of p65 subunit in the canonical pathway (Fig. 4 B and C) . We also found that leptin activated the noncanonical pathway by stimulating Rel B and p52 to enter the nucleus, indicating its potent activation of the NF-κB pathway (Fig. 4D) .
Leptin has been shown to activate CD40 promoter directly (10). However, addition of leptin to CD40 promoter luciferase construct-transfected 293T cells could not stimulate firefly luciferase activity, so we next generated a 293T cell line stably expressing the long functional isoform of the leptin receptor OB-Rb (293T-OB-Rb cells) (Figs. 4E and S3 G and H). We transfected 293T-OBRb cells with a construct containing either STAT3 enhancers or an NK-κB element fused to the 5′ end of the firefly luciferase, pSTAT3-TA-luc, or pTAL-NF-kB, respectively (Fig. 4F) . Leptin treatment significantly activated both the STAT3 enhancer and NK-κB element (Fig. 4F) . We also validated a direct role of leptin in activating the promoters of Bcl-2 and cyclin D1 by transfecting 293T-OB-Rb cells with constructs containing the promoter of either Bcl-2 or cyclin D1 fused to the 5′ end of the firefly luciferase (Fig. 4G) . Leptin treatment enhanced the normalized firefly luciferase activity in both transfections (Fig. 4G) . Finally, we sought to analyze whether leptin promotes B cells survival via induction of Bcl-2 and/or cyclin D1 by using nonreplicating lentiviruses that express siRNAs for Bcl-2 (LV-siBcl-2) and cyclin D1 (LV-sicyclin Data in A, B, E, and F are representative of four independent experiments, whereas data in C and D are representative of three independent experiments. Data are mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001. D1), respectively (Figs. 4H and S3D ). As expected, B cells infected with a lentivirus expressing the ORF of leptin (LV-leptin) showed up-regulated expression of Bcl-2 and cyclin D1 (Fig.  4I) . We then infected LPS-stimulated splenic B cells of both WT and db/db mice with the lentiviruses and found that the knockdown of Bcl-2 or cyclin D1 in WT and db/db B cells led to a smaller difference in live cell numbers between them, indicating that each factor partially mediates the prosurvival effects of leptin (Fig. 4J) . However, when B cells were infected with both LV-siBcl-2 and LV-sicyclin D1, the difference between WT and db/db B cell numbers was abolished, suggesting that Bcl-2 and cyclin D1 together contribute significantly to leptin-induced prosurvival responses. These findings were further confirmed in WT B cells with coinfection of LV-leptin or leptin treatment, and the effect was completely abolished with knockdown of both Bcl-2 and cyclin D1 (Fig. 4 K and L) . Similar results were obtained with malignant A20 cells (Fig. S3 A-F) .
Leptin Signaling Promotes B Cell Survival by Inhibiting Expression of miRNAs That Target the Putative 3′UTR of Bcl-2 and Cyclin D1. The 3′UTR of mRNA can be important for its stability (19) . To test whether leptin regulates Bcl-2 and/or cyclin D1 expression via their 3′UTRs, we performed a reporter assay by using a firefly luciferase chimeric plasmid containing the 3′UTR region of either Bcl-2 (pEZX-Bcl-2-3′UTR) or cyclin D1 (pEZX-Cyclin D1-3′ UTR) downstream of the firefly luciferase coding sequence and transfected that into 293T-OB-Rb cells (Fig. S4A) . Treatment with leptin enhanced the normalized firefly luciferase activity, All data are representative of three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001.
suggesting that leptin regulates expression of Bcl-2 and cyclin D1 through its effect on their 3′UTRs. Notably, both Bcl-2 and cyclin D1 possess a long 3′-UTR (∼5.1 kb and ∼2.7 kb, respectively), which are indicative of an expressional control mechanism via these regions (Fig. 5A) . To analyze whether the miRNA pathway mediates leptin-induced expression of Bcl-2 and cyclin D1 in B cells, we selected a panel of miRNAs that are predicted to target the 3′ UTR of Bcl-2 and cyclin D1 mRNAs (Fig. 5A) . We examined expression patterns for miRNA candidates in splenic B cells and shortlisted those that were expressed at high or medium levels (cycle threshold ≤30) (Fig. S4B) . We then examined the physiological effect of leptin on their expression levels by analyzing splenic B cells of WT mice versus db/db littermates (Fig.  S4C) , and confirmed the direct effect of leptin by incubating WT B cells with recombinant leptin in vitro (Fig. S4D) . Together, five and 14 miRNA candidates that can potentially target Bcl-2 and cyclin D1 respectively were also regulated by leptin in B cells (Fig.  S4E) . Transfection of A20 cells with these miRNA inhibitors upregulated d expression of Bcl-2 or cyclin D1 proteins (Fig. 5B) . To directly show whether these miRNAs can target the 3′UTR of Bcl-2 or cyclin D1 mRNA, we transfected 293T cells with pEZXBcl-2-3′UTR or pEZX-cyclin D1-3′UTR along with a mimic for each of the miRNAs (Fig. 5C ). Each transfection significantly inhibited the normalized firefly luciferase activity. We also found leptin overexpression in A20 cells inhibited expression of these miRNAs (Fig. S4F) . Moreover, transfection of A20 cells with the miRNA mimics impaired cell survival, suggesting that leptin can promote the survival of B cells with a possible impact on proliferation via the miRNA dependent mechanisms (Fig. 5D ).
Discussion
We have described two target molecules and two mechanisms through which leptin regulates B lymphocyte numbers. Experiments conducted with db/db leptin receptor defective mice and chimeras suggest that leptin promotes cell survival as well as cell cycle progression in the presence of costimulatory signals. Levels of the antiapoptotic protein Bcl-2 and the cell cycle regulator cyclin D1 are critical and function synergistically in these responses. Leptin controls expression of these proteins through at least two pathways: direct activation of their promoters and indirect stabilization of their 3′UTR via suppression of miRNAs. These findings further our understanding of homeostasis in the humoral immune system.
The capability of leptin to induce cyclin D1 expression is corroborative with its function in triggering cell cycle entry of B cells. Leptin alone was unable to induce DNA replication but profoundly enhanced G 1 /S transition in the presence of costimulation with anti-IgM, CD40L or LPS. Bcl-2 protein is an important regulator of B-cell homeostasis by regulating an intrinsic apoptosis pathway. Our findings that leptin activates Akt, STAT3, and NF-KB pathways are consistent with the link of these signaling molecules to Bcl-2 and cyclin D1 expression. In addition, our data that identify leptin as a B cell survival factor that protects B cells from apoptosis and induces cell cycle entry similar to the function of BAFF (20) . B cell development depends critically on BAFF, which initiates signaling and transcriptional programs including activation of Akt and NF-KB pathways and induction of antiapoptotic members of the Bcl-2 family as well as cyclin D1 and D2 expression (20, 21) . Although there are similar properties between leptin and BAFF signaling, whereas db/db B cells express normal level of BAFF receptor, they are not as responsive to BAFF stimulation as WT control, suggesting the possibility of the two cytokines sharing both common as well as nonredundant pathways (Fig. S2 G and H) . Notably, NF-KB, STAT3, and Akt signaling pathways are frequently activated in cancer cells including B lymphomas, suggesting that leptin signaling is likely to play a role in B-cell neoplasias (22, 23) . In addition, the high similarity of leptin's structural and signaling capabilities to those of IL-6 warrants further studies to determine its function in the regulation of B cell differentiation into plasma cells (24) .
In recent years, accumulating evidence of aberrant miRNA expression in B-cell-derived tumors underscores the importance of miRNA as potential targets for cancer therapeutics (9) . Recent studies have identified significant correlation between the expres- GAPDH was used as loading control for all Western blot analyses. (E) Quantitative RT-PCR analysis of relative mRNA levels of cyclin D1, cyclin D2, cyclin E1, cyclin A2, cyclin B1, CDK2, CDK4, and CDK6 in WT splenic total B cells treated with or without leptin (10 ng/mL) in the absence or presence of anti-IgM (10 μg/mL), CD40L (10 μg/mL), or LPS (10 μg/mL) for 6 h. Data are mean ± SD. All data are representative of three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001. sion of certain miRNAs and circulating leptin (25) . In this study, we show that leptin could suppress the expressions of a panel of miRNAs to mediate induction of gene expressions in B cells. We have also found that all of the leptin-modulated miRNAs that target the 3′UTR of Bcl-2 or cyclin D1 mRNAs are expressed at 3-to 160-fold higher in normal primary B cells than those in their malignant counterparts (Table S1 ). Although both Bcl-2 and cyclin D1 are frequently over-expressed in many B cell lymphoproliferative disorders, our observations suggest that leptin might play a role in B-cell malignancies via suppression of miRNAs leading to amplification of Bcl-2 and cyclin D1 during cancer development.
Nevertheless, although attempts to analyze Bcl-2 status associated with human B cell lymphoproliferative disorders have been successful, the initial attempts to establish cyclin D1 as a dominant Bcell oncogene were not, although it is speculated that the CDKs might play a role in the action of cyclin D1 (26) . Cyclin D1 is normally expressed at a very low level by B cells in the absence of growth factors, and our data show that knockdown of cyclin D1 alone has not impeded B cell survival as significantly as that of Bcl-2.
It is important to understand how leptin signaling is involved in such malignancies (17) . Further elucidation of the miRNA layer of the regulatory mechanisms for the function of leptin signaling in normal B cells and their malignant counterparts will benefit our understanding of not only B-cell physiology but also the development of potential targets for cancer therapy.
Materials and Methods
Mice and Cell Lines. Male C57BL/6 db/db, C57BL/6 wild-type (WT) control and C57BL/6 CD45.1 mice were obtained from the Jackson Laboratory. For generation of chimeric mice, 5 × 10 6 BM pre-B cells purified from 4-wk-old db/db or WT control littermates were injected with 3 × 10 6 B cell-depleted BM cells into the tail veins of C57BL/6 CD45.1 mice that had been irradiated at 9 Gy 1 d before transfer. All mice were maintained in a specific pathogen-free animal facility at the University of Hong Kong under the institutional guidelines for usage of experimental animals. All db/db and control mice had free access to food and water and were used at age of 4-5 wk before the onset of diabetes as revealed by normal blood glucose levels (112 ± 5 mg/dL) (27) . A20 and 293T cells were purchased from ATCC.
Flow Analysis and Cell Sorting. Immunostained cells were examined using a FACSCalibur flow cytometer and analyzed by CellQuest software (Becton Dickinson) (10, 27) . Cell sorting was performed with an EPICS-Altra flow cytometer (Beckman Coulter) and the purity of collected cells was routinely >96% (27) . Total B cells were also isolated using negative selection with magnetic microbeads according to manufacturer's instructions (Miltenyi Biotec).
Statistical Analysis. Data are presented as mean ± SD. Means were compared with the Student t test where appropriate for statistical analysis. Values of P 
GFP
+ cells were determined as in J. Data are mean ± SD. All data are representative of three independent experiments. *P < 0.01; **P < 0.001. < 0.05 are considered statistically significant. Unless otherwise specified, all studies are representative of at least three independent experiments.
Additional details including primer sequences for Tables S2-S5 are provided in SI Materials and Methods. ) were determined in triplicate cultures at 24 h. Data are mean ± SD. All data are representative of four independent experiments. *P < 0.01; **P < 0.001.
